TRAW Traws Pharma, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 14, 2026
$0,57
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$0,43rendah 52m
$3,27tinggi 52m
Kapitalisasi Pasar (MRQ)
$9M
P/E
1.4
EPS
$0.82
Pendapatan
$3M
lencana Anda
Rentang 52M
$0–$3
Peringkat Analis
HOLD
Target Harga
$1
P/E
1.4
ROE
·
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
TRAW Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$0.57
Kapitalisasi Pasar (MRQ)
$9M
P/E
1.4
EPS
$0.82
Pendapatan
$3M
Rentang 52M
$0–$3
TRAW Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Pemecahan saham
| Tanggal ex-dividen | Pemecahan | Tipe |
|---|---|---|
| 23 Sep. 2024 | 1-for-25 | Terbalik |
| 21 Mei 2021 | 1-for-15 | Terbalik |
| 26 Sep. 2018 | 1-for-15 | Terbalik |
| 1 Juni 2016 | 1-for-10 | Terbalik |
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$3M2016-12-31 → 2025-12-31
EPS$0.822020-12-31 → 2025-12-31
Arus Kas Bebas·2019-12-31 → 2019-12-31
Margin bersih·2016-12-31 → 2019-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | TRAW | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | 1.4rata-rata 5T ≈-16.8 | ≈-16.8 | · | · | |
| P/B (MRQ) | 5.1 | · | 2.0 | Terlalu mahal | |
| Harga / Nilai Buku Berwujud (MRQ) | -11.6rata-rata 5T ≈25.9 | ≈25.9 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | TRAW | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 0.9 | · | 4.4 | Likuiditas rendah |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | TRAW | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | 1134.5%rata-rata 5T ≈226.5% | ≈226.5% | · | · | |
| Revenue CAGR 3Y (CAGR Pendapatan 3T) | 131.1%rata-rata 5T ≈43.5% | ≈43.5% | · | · | |
| Revenue CAGR 5Y (CAGR Pendapatan 5T) | 64.6% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | TRAW | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$697.5K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
348.6%
Laporan Berikutnya
Nov 11, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 14, 2026 | $-0.18 | $-0.34 | 47.4% |
| 31 Maret 2026 | Mei 15, 2026 | $-0.53 | $-0.75 | 29.8% |
| 31 Des. 2025 | $0.63 | $-1.25 | 150.5% | |
| 31 Des. 2024 | $95.66 | $-9.74 | 1082.0% | |
| 30 Sep. 2024 | $95.66 | $-9.74 | 1082.0% | |
| 31 Des. 2023 | $-4.75 | $-6.46 | 26.5% | |
| 30 Sep. 2023 | $-5.75 | $-7.39 | 22.2% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3M | $226.0K | $226.0K | $226.0K | $226.0K | $231.0K | $2M | $1M | $787.0K | $6M | $11M | $800.0K | |
| R&D Expense | · | · | $11M | $11M | $7M | $17M | $16M | $17M | $19M | $20M | $26M | $49M | |
| SG&A Expense | $9M | $12M | $9M | $8M | $9M | $8M | $8M | $8M | $7M | $9M | $10M | $15M | |
| Operating Expenses | $21M | $143M | $21M | $20M | $17M | $25M | $24M | $25M | $27M | $29M | $35M | $65M | |
| Operating Income | $-18M | $-142M | $-20M | $-20M | $-16M | $-25M | $-22M | $-23M | $-26M | $-24M | $-24M | $-64M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $2.0K | |
| Interest Income | $455.0K | $510.0K | $1M | $651.0K | · | · | · | · | · | · | · | · | |
| Other Non-op | $478.0K | $289.0K | $1M | $663.0K | $12.0K | $48.0K | $143.0K | $1M | $30.0K | $62.0K | $-35.0K | $-52.0K | |
| Pretax Income | $9M | $-167M | $-19M | $-19M | $-16M | $-25M | $-21M | $-21M | $-24M | $-20M | $-24M | $-64M | |
| Income Tax | · | · | · | · | · | $4.0K | $10.0K | $-124.0K | $13.0K | $14.0K | $16.0K | $19.0K | |
| Net Income | $9M | $-167M | $-19M | $-19M | $-16M | $-25M | $-22M | $-21M | $-24M | $-20M | $-24M | $-64M | |
| EPS (Basic) | $0.83 | $-35.21 | $-22.57 | $-0.91 | $-0.96 | $-2.17 | · | · | · | · | · | · | |
| EPS (Diluted) | $0.82 | $-35.21 | $-22.57 | $-0.91 | $-0.96 | $-2.17 | · | · | · | · | · | · | |
| Shares (Basic) | 8,228,169 | 1,552,685 | 839,554 | 20,908,235 | 16,832,198 | 11,602,391 | · | · | · | · | · | · | |
| Shares (Diluted) | 8,376,380 | 1,552,685 | 839,554 | 20,908,235 | 16,832,198 | 11,602,391 | · | · | · | · | · | · | |
| EBITDA | · | · | · | · | · | · | $-22M | $-23M | · | $-24M | $-24M | $-63M |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | $21M | $39M | · | · | · | · | · | $21M | $20M | $44M | |
| Receivables | $4M | $2M | $18.0K | $29.0K | $28.0K | $37.0K | $98.0K | $35.0K | $59.0K | $31.0K | $2M | $132.0K | |
| Prepaid Expense | $365.0K | $2M | $2M | $561.0K | $332.0K | $722.0K | $650.0K | $760.0K | $820.0K | $2M | $2M | $3M | |
| Other Current Assets | $89.0K | $178.0K | $401.0K | $40.0K | $35.0K | $180.0K | $140.0K | $68.0K | $77.0K | $73.0K | $195.0K | $255.0K | |
| Current Assets | $8M | $25M | $23M | $39M | $55M | $20M | $23M | $18M | $5M | $23M | $23M | $47M | |
| PP&E (Net) | $7.0K | $10.0K | $22.0K | $24.0K | $38.0K | $52.0K | $50.0K | $9.0K | $64.0K | $152.0K | $248.0K | $420.0K | |
| PP&E (Gross) | · | · | $84.0K | $70.0K | $70.0K | $70.0K | $2M | $2M | $2M | $2M | $2M | $3M | |
| Accum. Depreciation | $77.0K | $74.0K | $62.0K | $46.0K | $32.0K | $18.0K | $2M | $2M | $2M | $2M | $2M | $2M | |
| Intangibles | $3M | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $104.0K | $1.0K | $1.0K | $1.0K | $10.0K | $150.0K | $150.0K | $149.0K | $12.0K | $12.0K | $12.0K | $12.0K | |
| Total Assets | $11M | $25M | $23M | $39M | $55M | $20M | $24M | $18M | $5M | $23M | $23M | $47M | |
| Accounts Payable | $6M | $8M | $6M | $4M | $3M | $5M | $4M | $4M | $6M | $5M | $3M | $4M | |
| Accrued Liabilities | $5M | $3M | $3M | $4M | $3M | $5M | $4M | $4M | · | · | · | · | |
| Current Liabilities | $11M | $12M | $9M | $8M | $6M | $10M | $8M | $8M | $10M | $10M | $8M | $10M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $1.0K | |
| Total Liabilities | $11M | $57M | $12M | $11M | $9M | $14M | $12M | $13M | $16M | $18M | $13M | $24M | |
| Common Stock | $90.0K | $36.0K | $9.0K | $209.0K | $209.0K | $124.0K | $1M | $57.0K | $8.0K | $68.0K | $25.0K | $217.0K | |
| Retained Earnings | $-640M | $-649M | $-483M | $-464M | $-445M | $-429M | $-403M | $-382M | $-362M | $-338M | $-319M | $-295M | |
| AOCI | $6.0K | $-42.0K | $-23.0K | $-33.0K | $-14.0K | $14.0K | $-18.0K | $-12.0K | $3.0K | $-31.0K | $-22.0K | $-13.0K | |
| Stockholders' Equity | $-629.0K | $-32M | $11M | $28M | $46M | $6M | $12M | $5M | $-12M | $4M | $10M | $23M | |
| Liabilities + Equity | $11M | $25M | $23M | $39M | $55M | $20M | $24M | $18M | $5M | $23M | $23M | $47M | |
| Shares Outstanding | 9,067,774 | 3,650,731 | 840,251 | 20,925,992 | 20,895,563 | 12,396,219 | 111,167,352 | 5,674,220 | 718,078 | 6,759,895 | 2,546,419 | 21,703,173 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $61.0K | $12.0K | $16.0K | $14.0K | $14.0K | $13.0K | $14.0K | $55.0K | $88.0K | $96.0K | $150.0K | $434.0K | |
| Stock-based Comp | $728.0K | $1M | $1M | $1M | $576.0K | $369.0K | $1M | $1M | $2M | $4M | $4M | $5M | |
| Deferred Tax | · | · | · | · | · | · | · | $-137.0K | · | $0 | $0 | $0 | |
| Amort. of Intangibles | $58.0K | $0 | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | $-390.0K | $-3M | · | $-171.0K | $-11M | $532.0K | |
| Operating Cash Flow | $-18M | $-30M | $-18M | $-16M | $-19M | $-23M | $-21M | $-23M | $-24M | $-16M | $-31M | $-58M | |
| CapEx | $3M | $4M | $14.0K | · | · | $15.0K | $55.0K | · | · | · | · | $228.0K | |
| Investing Cash Flow | $-3M | $-4M | $-14.0K | · | · | $-15.0K | $-55.0K | · | · | · | · | · | |
| Stock Issued | $6M | · | · | · | $55M | $9M | $22M | $35M | · | · | $7M | · | |
| Net Stock Activity | · | · | · | · | · | · | $22M | · | · | · | $7M | · | |
| Financing Cash Flow | $3M | $34M | · | · | $56M | $19M | $27M | $36M | $6M | $17M | · | · | |
| Net Change in Cash | $-18M | $517.0K | $-18M | $-16M | $36M | $-4M | $6M | $13M | $-17M | $2M | $-24M | $-16M | |
| Free Cash Flow | · | · | · | · | · | · | $-21M | · | · | · | · | $-58M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | $-58M |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | -994.0% | -1895.9% | · | -427.4% | -209.2% | -7968.0% | |
| Net Margin | · | · | · | · | · | · | -985.0% | -1675.3% | · | -354.6% | -209.3% | -7960.3% | |
| Pretax Margin | · | · | · | · | · | · | -984.6% | -1672.1% | · | -354.4% | -209.6% | -7972.0% | |
| EBITDA Margin | · | · | · | · | · | · | -993.4% | -1891.5% | · | -425.7% | -207.9% | -7913.8% | |
| ROA | · | · | · | · | · | · | -103.4% | -179.7% | · | -84.3% | -67.8% | -83.5% | |
| ROE | · | · | · | · | · | · | -777.3% | 652.7% | · | -274.9% | -146.4% | -123.5% | |
| ROIC | · | · | · | · | · | · | -187.6% | -429.6% | · | -552.0% | -239.6% | -280.3% |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | · | · | · | 2.8 | 2.1 | · | 2.3 | 3.0 | 4.6 | |
| Quick Ratio | · | · | · | · | · | · | 0.0 | 0.0 | · | 2.1 | 2.8 | 4.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -31872.0 |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | 0.1 | 0.1 | · | 0.2 | 0.3 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | 32.8 | 26.1 | · | 7.2 | 14.0 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | · | $0.10 | $0.95 | · | $0.64 | $0.39 | $1.05 | |
| Cash / Share | · | · | · | · | · | · | · | · | · | $3.17 | $0.78 | $2.01 | |
| EPS (TTM) | $0.82 | $-35.21 | $-22.57 | $-0.91 | $-0.96 | $-2.17 | · | · | · | · | · | · |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 1134.5% | 0.00% | 0.00% | 0.00% | -2.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 131.1% | 0.00% | -0.73% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 64.6% | · | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | $226.0K | $226.0K | $226.0K | $226.0K | $231.0K | $2M | $1M | $787.0K | $6M | $11M | $800.0K | |
| Net Income TTM | $9M | $-167M | $-19M | $-19M | $-16M | $-25M | $-22M | $-21M | $-24M | $-20M | $-24M | $-64M | |
| Market Cap | · | · | · | · | · | · | $15.84B | $4.49B | · | $86.32B | $1.38T | $4.02T | |
| P/E | 1.4 | -0.3 | -0.8 | -17.9 | -66.4 | -81.2 | · | · | · | · | · | · | |
| P/S | · | · | · | · | · | · | 7256.7 | 3656.1 | · | 15563.5 | 120030.2 | 5020554.3 | |
| P/B | · | · | · | · | · | · | 1368.7 | 833.4 | · | 20087.4 | 137369.3 | 176562.5 | |
| P / Tangible Book | · | · | 36.9 | 12.0 | 28.9 | 5307.3 | · | · | · | · | · | · | |
| P / Cash Flow | · | · | · | · | · | · | -760.5 | -197.8 | · | -5458.5 | -44019.0 | -69671.9 | |
| P / FCF | · | · | · | · | · | · | -758.5 | · | · | · | · | -69397.4 | |
| Earnings Yield | 72.6% | -396.5% | -120.4% | -5.6% | -1.5% | -1.2% | · | · | · | · | · | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $0 | $3M | $57.0K | $56.0K | $57.0K | $57.0K | $56.0K | $56.0K | $57.0K | $57.0K | $56.0K | $56.0K | $57.0K | |
| R&D Expense | $1M | $5M | · | · | $2M | $3M | · | · | · | $2M | · | $2M | $2M | $4M | $4M | $4M | |
| SG&A Expense | $3M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $2M | $3M | $2M | $3M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $3M | $7M | $7M | $4M | $4M | $5M | $5M | $9M | $123M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | |
| Operating Income | $-3M | $-7M | $-7M | $-4M | $-1M | $-5M | $-5M | $-9M | $-123M | $-5M | $-4M | $-5M | $-5M | $-6M | $-6M | $-6M | |
| Other Non-op | $-94.0K | $-2.0K | $14.0K | $96.0K | $188.0K | $180.0K | $-206.0K | $61.0K | $205.0K | $229.0K | $278.0K | $350.0K | $360.0K | $362.0K | $314.0K | $243.0K | |
| Net Income | $-3M | $-7M | $-7M | $-4M | $-915.0K | $21M | $-30M | $-8M | $-123M | $-5M | $-4M | $-5M | $-4M | $-6M | $-5M | $-5M | |
| EPS (Basic) | $-0.16 | $-0.53 | $-0.89 | $-0.34 | $-0.11 | $2.17 | $-7.28 | $-1.49 | $-20.52 | $-5.92 | $-16.45 | $-5.64 | $-0.20 | $-0.28 | $-0.26 | $-0.26 | |
| EPS (Diluted) | $-0.16 | $-0.53 | $-0.82 | $-0.34 | $-0.11 | $2.09 | $-7.28 | $-1.49 | $-20.52 | $-5.92 | $-16.45 | $-5.64 | $-0.20 | $-0.28 | $-0.26 | $-0.26 | |
| Shares (Basic) | 15,864,041 | 10,640,625 | · | 8,818,859 | 5,820,903 | 6,965,927 | · | 961,530 | 1,012,430 | 841,738 | · | 840,117 | 20,979,766 | 20,960,171 | · | 20,915,408 | |
| Shares (Diluted) | 15,864,041 | 10,640,625 | · | 8,818,859 | 5,820,903 | 7,215,125 | · | 961,530 | 1,012,430 | 841,738 | · | 840,117 | 20,979,766 | 20,960,171 | · | 20,915,408 | |
| EBITDA | $-3M | $-7M | · | $-4M | $-1M | $-5M | · | $-9M | $-123M | · | · | $-5M | $-5M | $-6M | · | $-6M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables | $3M | $2M | $4M | $2M | $1M | $2M | $2M | $2M | $18.0K | $18.0K | $18.0K | $18.0K | $17.0K | $17.0K | $29.0K | $28.0K | |
| Prepaid Expense | $553.0K | $845.0K | $365.0K | $1M | $966.0K | $1M | $2M | $1M | $2M | $2M | $2M | $2M | $704.0K | $802.0K | $561.0K | $1M | |
| Other Current Assets | $93.0K | $138.0K | $89.0K | $92.0K | $124.0K | $183.0K | $178.0K | $347.0K | $583.0K | $263.0K | $401.0K | $303.0K | $264.0K | $68.0K | $40.0K | $303.0K | |
| Current Assets | $9M | $6M | $8M | $10M | $15M | $19M | $25M | $9M | $19M | $18M | $23M | $27M | $30M | $35M | $39M | $44M | |
| PP&E (Net) | $5.0K | $6.0K | $7.0K | $7.0K | $8.0K | $9.0K | $10.0K | $12.0K | $14.0K | $18.0K | $22.0K | $26.0K | $17.0K | $21.0K | $24.0K | $28.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | $84.0K | $84.0K | $84.0K | · | $84.0K | $70.0K | $70.0K | · | $70.0K | |
| Accum. Depreciation | · | · | $77.0K | $77.0K | $76.0K | $75.0K | $74.0K | $72.0K | $70.0K | $66.0K | $62.0K | $58.0K | $53.0K | $49.0K | $46.0K | $42.0K | |
| Intangibles | $2M | $2M | $3M | $3M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $1.0K | $1.0K | $104.0K | $240.0K | $244.0K | $198.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Total Assets | $11M | $8M | $11M | $12M | $16M | $19M | $25M | $9M | $19M | $18M | $23M | $27M | $30M | $35M | $39M | $44M | |
| Accounts Payable | $6M | $8M | $6M | $5M | $5M | $8M | $8M | $5M | $6M | $7M | $6M | $6M | $5M | $5M | $4M | $4M | |
| Accrued Liabilities | $3M | $6M | $5M | $3M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | |
| Current Liabilities | $10M | $13M | $11M | $8M | $7M | $10M | $12M | $8M | $10M | $9M | $9M | $10M | $9M | $9M | $8M | $7M | |
| Total Liabilities | $10M | $13M | $11M | $8M | $7M | $13M | $57M | $11M | $13M | $12M | $12M | $13M | $12M | $12M | $11M | $10M | |
| Common Stock | $152.0K | $101.0K | $90.0K | $71.0K | $71.0K | $50.0K | $36.0K | $30.0K | $253.0K | $211.0K | $9.0K | $210.0K | $210.0K | $210.0K | $209.0K | $209.0K | |
| Retained Earnings | $-650M | $-647M | $-640M | $-633M | $-629M | $-628M | $-649M | $-619M | $-611M | $-488M | $-483M | $-478M | $-474M | $-469M | $-464M | $-458M | |
| AOCI | $-5.0K | $-2.0K | $6.0K | $6.0K | $9.0K | $-19.0K | $-42.0K | $-33.0K | $-33.0K | $-30.0K | $-23.0K | $-30.0K | $-28.0K | $-27.0K | $-33.0K | $-61.0K | |
| Stockholders' Equity | $2M | $-5M | $-629.0K | $5M | $8M | $6M | $-32M | $-2M | $-106M | $6M | $11M | $15M | $19M | $23M | $28M | $33M | |
| Liabilities + Equity | $11M | $8M | $11M | $12M | $16M | $19M | $25M | $9M | $19M | $18M | $23M | $27M | $30M | $35M | $39M | $44M | |
| Shares Outstanding | 15,264,812 | 10,162,587 | 9,067,774 | 7,131,151 | 7,069,148 | 5,075,390 | 3,650,731 | 3,025,554 | 25,306,509 | 21,085,935 | 840,251 | 21,003,409 | 20,977,625 | 20,969,559 | 20,925,992 | 20,925,992 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $44.0K | $44.0K | $44.0K | $15.0K | $1.0K | $1.0K | $2.0K | $2.0K | $4.0K | $4.0K | $4.0K | $5.0K | $4.0K | $3.0K | $4.0K | $3.0K | |
| Stock-based Comp | $816.0K | $634.0K | $327.0K | $135.0K | $105.0K | $161.0K | $334.0K | $343.0K | $380.0K | $333.0K | $332.0K | $360.0K | $273.0K | $336.0K | $330.0K | $305.0K | |
| Amort. of Intangibles | $43.0K | $43.0K | $44.0K | $14.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $4M | · | · | · | $-27M | · | · | · | · | · | · | · | $893.0K | · | · | |
| Operating Cash Flow | $-8M | $-3M | $-3M | $-4M | $-6M | $-5M | $-4M | $-11M | $-10M | $-4M | $-4M | $-4M | $-4M | $-5M | $-4M | $-4M | |
| CapEx | · | · | $0 | · | · | · | $0 | $0 | · | · | $0 | · | · | · | · | · | |
| Investing Cash Flow | · | · | $0 | · | · | · | $0 | $0 | · | · | $0 | · | · | · | · | · | |
| Stock Issued | $120.0K | $2M | $2M | $116.0K | $3M | $122.0K | · | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $2M | · | · | · | $122.0K | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $9M | $2M | $158.0K | $-62.0K | $3M | $13.0K | $20M | $0 | · | · | · | · | · | · | · | · | |
| Net Change in Cash | $2M | $-687.0K | $-3M | $-7M | $-3M | $-5M | $16M | $-11M | $496.0K | $-4M | $-4M | $-4M | $-4M | $-5M | $-4M | $-4M |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -45.7% | -9128.1% | · | -14975.4% | -216400.0% | · | · | -8928.1% | -8087.7% | -10958.9% | · | -9896.5% | |
| Net Margin | · | · | · | · | -33.5% | 37701.8% | · | -14868.4% | -216040.3% | · | · | -8314.0% | -7456.1% | -10312.5% | · | -9470.2% | |
| EBITDA Margin | · | · | · | · | -45.7% | -9126.3% | · | -14975.4% | -216400.0% | · | · | -8928.1% | -8087.7% | -10953.6% | · | -9896.5% | |
| ROA | -22.6% | -52.2% | · | -37.1% | -5.3% | 115.4% | · | -47.1% | -501.1% | · | · | -13.4% | -10.8% | -13.4% | · | -10.4% | |
| ROE | -61.4% | -2063.0% | · | -315.4% | 1.9% | 357.7% | · | -135.8% | 284.3% | · | · | -19.8% | -14.8% | -17.7% | · | -13.0% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.4 | · | 1.2 | 2.1 | 1.8 | · | 1.1 | 1.9 | · | · | 2.8 | 3.5 | 3.8 | · | 6.0 | |
| Quick Ratio | 0.4 | 0.1 | · | 0.3 | 0.2 | 0.2 | · | 0.3 | 0.0 | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.2 | 0.0 | · | 0.0 | 0.0 | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | 4.1 | 0.1 | · | 0.1 | 3.3 | · | · | 2.5 | 2.5 | 2.5 | · | 2.0 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.11 | $-0.52 | · | $0.64 | $1.17 | $1.18 | · | $-0.67 | $-4.17 | · | · | $0.69 | $0.90 | $1.09 | · | $1.59 | |
| Revenue / Share | · | · | · | · | $0.47 | $0.01 | · | $0.06 | $0.00 | · | · | $0.00 | $0.00 | $0.00 | · | $0.00 | |
| Cash Flow / Share | · | $-0.24 | · | · | · | $-0.75 | · | · | · | · | · | · | · | $-0.22 | · | · | |
| EPS (TTM) | $-1.85 | $-1.80 | · | $-5.64 | $-6.79 | $-27.20 | · | $-44.38 | $-48.53 | $-28.21 | · | $-6.38 | $-1.00 | $-0.99 | · | $-0.80 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | $3M | · | $3M | $3M | $227.0K | · | $226.0K | $226.0K | $226.0K | · | $226.0K | $226.0K | $226.0K | · | $226.0K | |
| Net Income TTM | $-22M | $-19M | · | $-13M | $-18M | $-140M | · | $-141M | $-137M | $-18M | · | $-20M | $-21M | $-21M | · | $-17M | |
| Market Cap | $13M | $19M | · | $13M | $10M | $12M | · | $18M | $285M | · | · | $373M | $619M | $383M | · | $460M | |
| P/E | -0.5 | -1.0 | · | -0.3 | -0.2 | -0.1 | · | -0.1 | -0.2 | -0.9 | · | -2.8 | -29.5 | -18.4 | · | -27.5 | |
| P/S | 4.6 | 6.7 | · | 4.6 | 3.6 | 51.4 | · | 78.7 | 1259.7 | · | · | 1649.6 | 2738.2 | 1693.3 | · | 2037.0 | |
| P/B | 7.6 | -3.5 | · | 2.9 | 1.3 | 1.9 | · | -8.8 | -2.7 | · | · | 25.7 | 32.7 | 16.7 | · | 13.8 | |
| P / Tangible Book | · | · | · | 6.7 | 1.3 | 1.9 | · | · | · | 88.5 | · | 25.7 | 32.7 | 16.7 | · | 13.8 | |
| P / Cash Flow | · | -7.2 | · | · | · | -2.1 | · | · | · | · | · | · | · | -84.2 | · | · | |
| Earnings Yield | -220.2% | -98.4% | · | -304.9% | -458.8% | -1182.6% | · | -754.8% | -431.4% | -111.7% | · | -35.9% | -3.4% | -5.4% | · | -3.6% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $3M | $226.0K | $226.0K | $226.0K | $226.0K |
| Laba Bersih | $9M | $-167M | $-19M | $-19M | $-16M |
| EPS Dilusian | $0.82 | $-35.21 | $-22.57 | $-0.91 | $-0.96 |
Tidak ada data untuk laporan ini
Data fundamental belum cukup untuk membuat laporan ini.
Tidak ada data untuk laporan ini
Data fundamental belum cukup untuk membuat laporan ini.
Pemilik institusional (13F) 35 pengaju · $5.2M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
35
Nilai yang dipegang
$5.2M
Posisi baru
13
Posisi yang keluar
6
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 13 (-1 vs Kuartal sebelumnya) | 6 (-1 vs Kuartal sebelumnya) | 9 (+7 vs Kuartal sebelumnya) | 8 (+4 vs Kuartal sebelumnya) | +2.5M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | $1.014.709 | 1.203.260 | 19,55% | Saham |
| Ally Bridge Group (NY) LLC | $663.033 | 786.236 | 12,77% | Saham |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $615.609 | 730.000 | 11,86% | Saham |
| ADAR1 Capital Management, LLC | $504.065 | 597.729 | 9,71% | Saham |
| Lynx1 Capital Management LP | $471.801 | 559.470 | 9,09% | Saham |
| Ikarian Capital, LLC | $403.217 | 478.142 | 7,77% | Saham |
| SPHERA FUNDS MANAGEMENT LTD. | $336.043 | 398.486 | 6,47% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $278.231 | 330.049 | 5,36% | Saham |
| JANE STREET GROUP, LLC | $182.158 | 216.006 | 3,51% | Saham |
| Alyeska Investment Group, L.P. | $138.618 | 164.376 | 2,67% | Saham |
| BOOTHBAY FUND MANAGEMENT, LLC | $112.948 | 133.936 | 2,18% | Saham |
| VANGUARD GROUP INC | $98.603 | 87.259 | 1,90% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $93.915 | 111.365 | 1,81% | Saham |
| Kynam Capital Management, LP | $71.175 | 84.400 | 1,37% | Saham |
| Dauntless Investment Group, LLC | $67.948 | 80.574 | 1,31% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $45.953 | 54.511 | 0,89% | Saham |
| NORTHERN TRUST CORP | $31.585 | 37.454 | 0,61% | Saham |
| STATE STREET CORP | $21.759 | 25.802 | 0,42% | Saham |
| XTX Topco Ltd | $15.257 | 18.092 | 0,29% | Saham |
| BlackRock, Inc. | $8.383 | 9.941 | 0,16% | Saham |
| Tower Research Capital LLC (TRC) | $4.336 | 5.142 | 0,08% | Saham |
| HUNTINGTON NATIONAL BANK | $3.943 | 4.676 | 0,08% | Saham |
| UBS Group AG | $2.909 | 3.451 | 0,06% | Saham |
| BARCLAYS PLC | $1.642 | 1.947 | 0,03% | Saham |
| SBI Securities Co., Ltd. | $1.451 | 1.721 | 0,03% | Saham |
| Federation des caisses Desjardins du Quebec | $414 | 500 | 0,01% | Saham |
| MORGAN STANLEY | $395 | 468 | 0,01% | Saham |
| Vanguard Global Advisers, LLC | $221 | 262 | 0,00% | Saham |
| HRT FINANCIAL LP | $76 | 91.220 | 0,00% | Saham |
| SG Americas Securities, LLC | $12 | 14.524 | 0,00% | Saham |
| Virtu Financial LLC | $11 | 12.579 | 0,00% | Saham |
| Cassaday & Co Wealth Management LLC | $6 | 6 | 0,00% | Saham |
| HARBOUR INVESTMENTS, INC. | $4 | 5 | 0,00% | Saham |
| JONES FINANCIAL COMPANIES LLLP | $2 | 2 | 0,00% | Saham |
| FMR LLC | $2 | 2 | 0,00% | Saham |
Aktivis & pemilik 5%+ 5 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC, OrbiMed Capital GP VIII LLC ×4 pengajuan | 5 Mei 2026 | 11,90% | Amandemen | · | SEC |
| Viriom, Inc., Nikolay Savchuk, Iain D. Dukes | 8 April 2024 | · | Pengajuan awal | M&A / penjualan | SEC |
| 683 Capital Partners, LP, 683 Capital Management, LLC, Ari Zweiman ×5 pengajuan | 19 Feb. 2020 | · | Pengajuan awal | · | SEC |
| Michael B. Hoffman, Michael and Jane Hoffman 2018 Descendants Trust ×3 pengajuan | 27 Juli 2018 | · | Pengajuan awal | Investasi pasif | SEC |
| E. Premkumar Reddy ×2 pengajuan | 26 Feb. 2018 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 35 orang dalam · 16 pejabat · 18 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Iain D. Dukes | Chief Executive Officer | 9 Juli 2026 A | 171.130 | 0 | 0 | $0 |
| Ramesh Kumar | Chief Executive Officer | 26 Juli 2018 A | 102.227 | 0 | 0 | $0 |
| Charles Nolan Parker | Chief Financial Officer | 9 Juli 2026 A | 15.393 | 0 | 0 | $0 |
| Mark Patrick Guerin | CFO | 18 Juni 2024 M | 39.255 | 0 | 0 | $0 |
| Ajay Bansal | Chief Financial Officer | 26 Jan. 2016 A | 43.846 | 0 | 0 | $0 |
| Steven M Fruchtman | PRESIDENT, CHIEF EXECUTIVE OFF | 13 Maret 2024 M | 74.792 | 0 | 0 | $0 |
| Thomas J Mckearn | President, R&D | 26 Jan. 2016 A | 3.333 | 0 | 0 | $0 |
| Nikolay Savchuk | Chief Operating Officer | 9 Juli 2026 A | 150.606 | 0 | 0 | $0 |
| Robert Redfield | Chief Medical Officer | 9 Juli 2026 A | 113.919 | 0 | 0 | $0 |
| Charles David Pauza | Chief Science Officer Virology | 9 Juli 2026 A | 115.971 | 0 | 0 | $0 |
| Victor M Moyo | CHIEF MEDICAL OFFICER | 2 Okt. 2023 A | · | 0 | 0 | $0 |
| Mark S. Gelder MD | CHIEF MEDICAL OFFICER | 13 Maret 2023 A | 10.487 | 0 | 0 | $0 |
| Abraham N. Oler | SVP Corp Dev & Gen Counsel | 7 Feb. 2022 A | 24.514 | 0 | 0 | $0 |
| Richard Charles Woodman | Chief Medical Officer | 9 Juli 2020 A | · | 0 | 0 | $0 |
| Manoj Maniar | SVP - Product Development | 9 Juli 2020 A | 50 | 0 | 0 | $0 |
| James Altland | SVP, Finance & Corp. Develop. | 20 Des. 2013 A | 10.000 | 0 | 0 | $0 |
| Trafford Clarke | Direktur | 9 Juli 2026 A | 6.157 | 0 | 0 | $0 |
| Mary Teresa Shoemaker | Direktur | 9 Juli 2026 A | 6.292 | 0 | 0 | $0 |
| John Harold Leaman | Direktur | 9 Juli 2026 A | 4.058 | 0 | 0 | $0 |
| Werner Cautreels | Direktur | 9 Juli 2026 A | 109.222 | 0 | 0 | $0 |
| Jack E Stover | Direktur | 9 Juli 2026 A | 6.165 | 0 | 0 | $0 |
| Luba Greenwood | Direktur | 16 Sep. 2024 A | · | 0 | 0 | $0 |
| Peter Atadja | Direktur | 10 Agu 2023 A | · | 0 | 0 | $0 |
| Viren Mehta | Direktur | 10 Agu 2023 A | 250.857 | 0 | 0 | $0 |
| Jerome Groopman | Direktur | 10 Agu 2023 A | 10.001 | 0 | 0 | $0 |
| James J Marino | Direktur | 10 Agu 2023 A | 21.334 | 0 | 0 | $0 |
| Premkumar E Reddy | Direktur | 27 Agu 2020 S | 16.683 | 0 | 0 | $0 |
| Michael B Hoffman | Direktur | 27 Agu 2020 S | 0 | 0 | 0 | $0 |
| Henry S Bienen | Direktur | 29 Mei 2018 P | 22.724 | 0 | 0 | $0 |
| Anne Vanlent | Direktur | 15 Juni 2015 A | · | 0 | 0 | $0 |
| TPAV, LLC | Pemilik 10% | 29 Des. 2024 P | · | 0 | 0 | $0 |
| TYNDALL CAPITAL PARTNERS L P | Pemilik 10% | 24 Sep. 2019 S | 616.389 | 0 | 0 | $0 |
| 683 Capital Management, LLC | Pemilik 10% | 27 April 2018 P | 14.503.169 | 0 | 0 | $0 |
| Baxter Healthcare SA | Pemilik 10% | 6 Mei 2015 J | 0 | 0 | 0 | $0 |
| Michael & Jane Hoffman 2013 Descendants | Pemilik 10% | 21 Feb. 2014 P | 4.518.275 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 2 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
TRAW Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 7 analis
JUAL
Target median
$1.00
+75,9%
0 0,0%
Beli Kuat
0 0,0%
Beli
4 57,1%
Tahan
1 14,3%
Jual
2 28,6%
Jual Kuat
Target Harga 12 Bulan
1 analis · 2026-09-30Target rata-rata $1.00 +75,9%
Rendah$1.00
Rata-rata$1.00
Tinggi$1.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 14, 2026